Back to search

Article

Modelling immune gene expression profiles as pharmacodynamic endpoints of antileishmanial treatment

2025-06-18

Abstract excerpt

<h4>Background: </h4> Cutaneous leishmaniasis (CL), a neglected infectious disease caused by the intracellular protozoan parasite Leishmania, affects over one million people annually. The type and magnitude of the inflammatory response elicited during infection leads to skin-specific immunopathology, resulting in the clinical manifestations of CL. Systemic antileishmanial drugs are the main control measure; howev...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ec2cae2a-d243-5efa-b229-ef27ed19fd9a
DOI
10.22541/au.175024995.51140065/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Modelling immune gene expression profiles as pharmacodynamic endpoints of antileishmanial treatmentDOI 10.22541/au.175024995.51140065/v1
Select a neighboring publication to make it the new centre.